Related references
Note: Only part of the references are listed.The Effect of Everolimus Versus Mycophenolate Upon Proteinuria Following Kidney Transplant and Relationship to Graft Outcomes
A. C. Wiseman et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study
K. Budde et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Donor-Specific HLA Antibodies in a Cohort Comparing Everolimus with Cyclosporine After Kidney Transplantation
L. Liefeldt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation
L. Mjornstedt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36 months after transplantation
Markus Guba et al.
TRANSPLANT INTERNATIONAL (2012)
The Histology of Solitary Renal Allografts at 1 and 5 Years After Transplantation
M. D. Stegall et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Specificity of Histological Markers of Long-Term CNI Nephrotoxicity in Kidney-Transplant Recipients Under Low-Dose Cyclosporine Therapy
R. Snanoudj et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study
Y. Lebranchu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
The ORION Study: Comparison of Two Sirolimus-Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients
S. M. Flechner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Chronic Calcineurin Inhibitor Nephrotoxicity-Lest We Forget
J. R. Chapman
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Chronic Progressive Calcineurin Nephrotoxicity: An Overstated Concept
Arthur J. Matas
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial
Matthew R. Weir et al.
KIDNEY INTERNATIONAL (2011)
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial
Klemens Budde et al.
LANCET (2011)
Results of a Prospective Randomized Trial of Sirolimus Conversion in Kidney Transplant Recipients on Early Corticosteroid Withdrawal
Raymond. L. Heilman et al.
TRANSPLANTATION (2011)
Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study
Hallvard Holdaas et al.
TRANSPLANTATION (2011)
Pathological and Clinical Characterization of the 'Troubled Transplant': Data from the DeKAF Study
S. Gourishankar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Renal Function, Efficacy, and Safety of Sirolimus and Mycophenolate Mofetil After Short-Term Calcineurin Inhibitor-Based Quadruple Therapy in De Novo Renal Transplant Patients: One-Year Analysis of a Randomized Multicenter Trial
Markus Guba et al.
TRANSPLANTATION (2010)
Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure
Robert S. Gaston et al.
TRANSPLANTATION (2010)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study
Y. Lebranchu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts
Nils Lachmann et al.
TRANSPLANTATION (2009)
Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
Francesco P. Schena et al.
TRANSPLANTATION (2009)
Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients
A. Z. Aliabadi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period
F. L. Luan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients
Ahmed F. Hamdy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus
Patrick G. Dean et al.
TRANSPLANTATION (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat
Regina Vogelbacher et al.
TRANSPLANTATION (2007)
Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors:: comparison of two CNI-free protocols
Fritz Dickmann et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs
Stuart M. Flechner et al.
TRANSPLANTATION (2007)
Proteinuria in transplant patients associated with sirolimus
A. F. V. Franco et al.
TRANSPLANTATION PROCEEDINGS (2007)
Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: A systematic review of the evidence
Atul V. Mulay et al.
TRANSPLANTATION (2006)
Cardiovascular complications after renal transplantation and their prevention
Akinlolu O. Ojo
TRANSPLANTATION (2006)
Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function
Lorenzo G. Gallon et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus
TS Larson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
The place of sirolimus in kidney transplantation: Can we reduce calcineurin inhibitor renal toxicity?
R. J. Knight et al.
KIDNEY INTERNATIONAL (2006)
Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation
M Hourmant et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion
JP Pearl et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation
A Lo et al.
TRANSPLANTATION (2004)
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era
HU Meier-Kriesche et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up
S Aakhus et al.
CLINICAL TRANSPLANTATION (2004)
Performance of different prediction equations for estimating renal function in kidney transplantation
F Gaspari et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: A case for albuminuria
NS Anavekar et al.
KIDNEY INTERNATIONAL (2004)
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years
SM Flechner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Long-term graft survival with neoral and tacrolimus: A paired kidney analysis
B Kaplan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporin
SM Flechner et al.
TRANSPLANTATION (2002)
Proteinuria after renal transplantation affects not only graft survival but also patient survival
JL Roodnat et al.
TRANSPLANTATION (2001)
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients
H Kreis et al.
TRANSPLANTATION (2000)
Share Paper
